Clinical trialNCT07211178RecruitingObservational

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

SponsorTempus AIEnrollment900Breast CancerEarly Stage Breast CancerHER2 + Breast CancerHR Positive/HER-2 Negative Breast CancerTNBC - Triple-Negative Breast Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michelle Ting-Lin, MD
Tempus AI
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Birmingham Hematology Associates
Birmingham, Alabama, United States
Matthew Tucker
Recruiting
Pih Health Whittier Hospital
Whittier, California, United States
Lisa Wang
Recruiting
Cleveland Clinic Florida
Weston, Florida, United States
Thomas Samuel, MD
Recruiting
Southern Illinois Hospital Services
Carbondale, Illinois, United States
Mohammad Popalzi
Recruiting
Cancer Care Specialist of Illinois
O'Fallon, Illinois, United States
James Wade
Recruiting
Goshen Center for Cancer Care
Goshen, Indiana, United States
James Wheeler
Recruiting
Trinity Health
Ann Arbor, Michigan, United States
Tareq Al baghdadi
Recruiting
Oncology Hematology Associates
Springfield, Missouri, United States
Roger Holden
Recruiting
Cancer Care Specialist of Reno
Reno, Nevada, United States
Sowjanya Reganti
Recruiting
Summit Medical Group
Florham Park, New Jersey, United States
Steven Parish
Recruiting
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Kerri McGovern, MD
Recruiting
Nashville General
Nashville, Tennessee, United States
Robin Jacob
Recruiting
Cancer Care Northwest
Spokane Valley, Washington, United States
Nikolas Rademaker
Recruiting
Gunderson Health
La Crosse, Wisconsin, United States
Paul Letendre
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Oct 2025
Primary completion: 31 Dec 2032
Completion: 31 Dec 2033
Last update posted: 12 Jun 2026
Registered enrollment: 900
Registry id: NCT07211178

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.